DNA Synthesis Related News

Twist Bioscience and the BioBricks Foundation Announce Partnership to Provide 10,000 Public-Benefit Genes to the Synthetic Biology Community

SAN FRANCISCO, Calif. – June 15, 2017 – Twist Bioscience, a company accelerating science and innovation through rapid, high-quality DNA synthesis, and the BioBricks Foundation today announced a groundbreaking agreement to provide 10,000 genes to the synthetic biology community. Under [...]

By | June 15th, 2017|DNA Synthesis, Industry Providers, News, Press Releases|

Twist Bioscience and BioBricks Foundation Announce Unique Partnership

Twist Bioscience, a leader in the field of DNA synthesis, and BioBricks Foundation, a charity foundation for the advancement of biotechnology, announced today an agreement to provide 10,000 genes to the synthetic biology community. With this pioneering agreement, BioBricks will [...]

By | June 15th, 2017|DNA Synthesis, Industry Providers, News, Press Releases|

Twist Bioscience Adds $27 Million to its 2017 Financing

Twist Bioscience, the rising star of DNA synthesis, has announced the completion of its most recent financing round with the addition of $27 million to the raise.  In combination with the $33 million in funding that Twist announced in March, [...]

By | June 15th, 2017|DNA Synthesis, Industry Providers, News, Press Releases|

Integrated DNA Technologies Launches New Grant Program Aimed at Synthetic Biology Startups

Integrated DNA Technologies, the world’s largest manufacturer of nucleic acids, has announced the launch of a new grant program specifically aimed at supporting synthetic biology startups. The grant is dedicated to enabling research and development early stage companies by supplying [...]

By | June 5th, 2017|DNA Synthesis, Industry Providers, News|

Synthetic Genomics Launches cGMP Suite for Pharmaceutical Quality Manufacturing of Synthetic DNA for Advaxis’ Clinical Trials

SAN DIEGO, June 1, 2017 — Synthetic Genomics, Inc. and Advaxis, Inc. (NASDAQ:ADXS) announced today that they have completed development and deployment of the first current good manufacturing practice (cGMP) synthetic biology facility for the production of synthetic DNA constructs. [...]

By | June 1st, 2017|DNA Synthesis, Industry Providers, News, Press Releases|

Digital-to-Biological Converter for On-Demand Production of Biologics Developed by Synthetic Genomics, Inc.

SAN DIEGO, May 29, 2017 — Synthetic Genomics, Inc. announced today the publication of a peer reviewed article describing the development and operation of its digital-to-biological converter (DBC) prototype that produced biologic compounds on-demand without any human intervention. The DBC [...]